Clinical Trial Update: Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy [Phase 3]

View source ↗

Summary

Phase 3 trial of Nomacopan for transplant-associated thrombotic microangiopathy was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombotic Microangiopathy
• Transplant-associated Thrombotic Microangiopathy

Drugs mentioned

• Nomacopan (rVA576) (nomacopan)

Snippet

Sponsor: AKARI Therapeutics | Conditions: Thrombotic Microangiopathies | Phase 3 | Status: TERMINATED | Results posted: 2025-05-15